Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study.
Saved in:
| Title: | Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study. |
|---|---|
| Authors: | Savolainen M; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland., Soilu-Hänninen M; Neurocenter, Turku University Hospital and Division of Clinical Neurosciences, University of Turku, Turku, Finland., Nurmi H; StellarQ Ltd, Turku, Finland., Viitala M; Aastat Ltd, Turku, Finland., Tienari P; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland., Atula S; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland., Laakso SM; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland. |
| Source: | European journal of neurology [Eur J Neurol] 2026 May; Vol. 33 (5), pp. e70625. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1468-1331 |
|---|---|
| DOI: | 10.1111/ene.70625 |
